Symbol |
Name |
ACTN2
|
actinin, alpha 2
|
ADAM17
|
ADAM metallopeptidase domain 17
|
ADORA1
|
adenosine A1 receptor
|
ADRA2A
|
adrenoceptor alpha 2A
|
ADRA2B
|
adrenoceptor alpha 2B
|
ADRA2C
|
adrenoceptor alpha 2C
|
AGRN
|
agrin
|
ANXA2
|
annexin A2
|
APLP2
|
amyloid beta (A4) precursor-like protein 2
|
APP
|
amyloid beta (A4) precursor protein
|
BAZ1B
|
bromodomain adjacent to zinc finger domain, 1B
|
BICD1
|
bicaudal D homolog 1 (Drosophila)
|
CACNG2
|
calcium channel, voltage-dependent, gamma subunit 2
|
CACNG3
|
calcium channel, voltage-dependent, gamma subunit 3
|
CACNG4
|
calcium channel, voltage-dependent, gamma subunit 4
|
CACNG5
|
calcium channel, voltage-dependent, gamma subunit 5
|
CACNG7
|
calcium channel, voltage-dependent, gamma subunit 7
|
CACNG8
|
calcium channel, voltage-dependent, gamma subunit 8
|
CAV3
|
caveolin 3
|
CBLC
|
Cbl proto-oncogene C, E3 ubiquitin protein ligase
|
CDK5
|
cyclin-dependent kinase 5
|
CNIH2
|
cornichon family AMPA receptor auxiliary protein 2
|
CNIH3
|
cornichon family AMPA receptor auxiliary protein 3
|
CRH
|
corticotropin releasing hormone
|
CRHBP
|
corticotropin releasing hormone binding protein
|
DAPK1
|
death-associated protein kinase 1
|
DLG4
|
discs, large homolog 4 (Drosophila)
|
EGF
|
epidermal growth factor
|
EPGN
|
epithelial mitogen
|
EREG
|
epiregulin
|
ERRFI1
|
ERBB receptor feedback inhibitor 1
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
FNTA
|
farnesyltransferase, CAAX box, alpha
|
FOXH1
|
forkhead box H1
|
GREM1
|
gremlin 1, DAN family BMP antagonist
|
GSG1L
|
GSG1-like
|
HAP1
|
huntingtin-associated protein 1
|
HDAC6
|
histone deacetylase 6
|
HEYL
|
hes-related family bHLH transcription factor with YRPW motif-like
|
HTT
|
huntingtin
|
IGF2
|
insulin-like growth factor 2
|
MAPK8IP2
|
mitogen-activated protein kinase 8 interacting protein 2
|
MED1
|
mediator complex subunit 1
|
MED16
|
mediator complex subunit 16
|
MEF2C
|
myocyte enhancer factor 2C
|
MINK1
|
misshapen-like kinase 1
|
MYO5A
|
myosin VA (heavy chain 12, myoxin)
|
NCK2
|
NCK adaptor protein 2
|
NCOA2
|
nuclear receptor coactivator 2
|
NCOA3
|
nuclear receptor coactivator 3
|
NETO2
|
neuropilin (NRP) and tolloid (TLL)-like 2
|
NEURL1
|
neuralized E3 ubiquitin protein ligase 1
|
NLGN1
|
neuroligin 1
|
NLGN2
|
neuroligin 2
|
NLGN3
|
neuroligin 3
|
OPRM1
|
opioid receptor, mu 1
|
P2RY1
|
purinergic receptor P2Y, G-protein coupled, 1
|
PARK7
|
parkinson protein 7
|
PCSK9
|
proprotein convertase subtilisin/kexin type 9
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
PLAU
|
plasminogen activator, urokinase
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
PPARGC1B
|
peroxisome proliferator-activated receptor gamma, coactivator 1 beta
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
PRKCD
|
protein kinase C, delta
|
PRKCE
|
protein kinase C, epsilon
|
PSEN1
|
presenilin 1
|
PSEN2
|
presenilin 2
|
PTK2B
|
protein tyrosine kinase 2 beta
|
PTPRJ
|
protein tyrosine phosphatase, receptor type, J
|
RASGRF1
|
Ras protein-specific guanine nucleotide-releasing factor 1
|
RASGRF2
|
Ras protein-specific guanine nucleotide-releasing factor 2
|
RELN
|
reelin
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
SHANK1
|
SH3 and multiple ankyrin repeat domains 1
|
SHANK3
|
SH3 and multiple ankyrin repeat domains 3
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
SNX6
|
sorting nexin 6
|
SOCS4
|
suppressor of cytokine signaling 4
|
SOCS5
|
suppressor of cytokine signaling 5
|
SRA1
|
steroid receptor RNA activator 1
|
TGFA
|
transforming growth factor, alpha
|
UBE2I
|
ubiquitin-conjugating enzyme E2I
|
ZFYVE28
|
zinc finger, FYVE domain containing 28
|
ZGPAT
|
zinc finger, CCCH-type with G patch domain
|